Exclusive

Publication

Byline

EQT to Acquire QIAGEN in Landmark €10.8 Billion Take-Private Deal

Singapore, Oct. 22 -- QIAGEN N.V. and EQT XI fund ("EQT Private Equity") announced an agreement under which Crown NL Bidco B.V. (the "Bidder") announced its decision to make an all-cash voluntary publ... Read More


Mubadala Bio inks strategic partnership with Marcyrl Group to localise broad portfolio of women's health in UAE

Singapore, Oct. 22 -- Mubadala Bio has signed a strategic partnership with Marcyrl Pharmaceutical Industries (Marcyrl Group) to localise a broad portfolio of women's health, fertility and respiratory ... Read More


NUS researchers identify how ovarian tissue stiffness can impair egg development

Singapore, Oct. 22 -- Researchers at the National University of Singapore (NUS) have identified how a stiffer ovarian environment can disrupt communication between developing eggs and their supporting... Read More


Samsung Biologics raises 2026 growth outlook as quarterly revenue reaches KRW 1.49 trillion

Singapore, Oct. 22 -- Samsung Biologics reported third-quarter revenue of KRW 1.49 trillion and operating profit of KRW 640 billion, supported by manufacturing activity in Korea and initial revenue co... Read More


Shionogi and F2G report Phase 3 results for oral antifungal olorofim

Singapore, Oct. 22 -- Shionogi and F2G have reported detailed results from the global Phase 3 OASIS study evaluating investigational oral antifungal olorofim against AmBisome, followed by standard of ... Read More


DOBBS Community and OncoCare strengthen early cancer detection pathways in Malaysia

Singapore, Oct. 22 -- DOBBS Community and OncoCare have joined forces to strengthen cancer awareness, early detection and access to appropriate specialist care in Malaysia through the GP Onco Navigato... Read More


Healthcare's AI Ambitions Are Colliding With a Data Wall

Singapore, Oct. 21 -- Healthcare is generating more data than ever, yet much of its potential remains locked within disconnected systems. As artificial intelligence reshapes clinical decision-making a... Read More


Nxera Pharma Japan licenses Quviviq to Taiwan's Synmosa Biopharma in 8 APAC markets

Singapore, Oct. 19 -- Nxera Pharma has announced that its subsidiary, Nxera Pharma Japan has entered into an exclusive license, supply and commercialisation agreement with Taiwan-headquartered Synmosa... Read More


S2N.Bio begins Alzheimer's cell therapy technology transfer to Cell Therapies' Melbourne GMP facility

Singapore, Oct. 19 -- Cell Therapies Pty Ltd (CTPL) and S2N.Bio have commenced technology transfer of S2N's cell therapy candidate for Alzheimer's disease. The transfer will enable GMP manufacture of ... Read More


HistoIndex partners with A*STAR to advance early-stage development of pipeline therapies for fibrotic diseases in Singapore

Singapore, Oct. 19 -- HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agenc... Read More